10 Results for "

BGT1

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "BGT1" in MCE Product Catalog:

Cat. No.: HY-103509
CAS No.: 184845-18-9
Purity:  99.09%
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

NNC 05-2090 hydrochloride is a GABA uptake inhibitor and inhibitor of the β-GABA transporter (BGT-1) (IC50< /sub>: 10.6 μM). NNC 05-2090 hydrochloride also inhibits mGAT2 with a Ki value of 1.4 μM. NNC 05-2090 has anticonvulsant activity and can be used in the study of epilepsy and neurological diseases [1] .
loading...
    loading...
Cat. No.: HY-119591
CAS No.: 312281-74-6
Purity:  98.45%
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

BPDBA is a selective and noncompetitive betaine/GABA transporter (BGT-1) inhibitor with IC50s of 20 μM and 35 μM against human BGT-1 and mouse GAT2, respectively [1].
loading...
    loading...
Cat. No.: HY-124285
CAS No.: 185444-92-2
Purity:  ≥95.0%
Target:  

GABA Receptor

Research Areas:  

Others

ATPCA hydrochloride is a selective radioactive substrate for BGT1 over GAT1/GAT3 [1].
loading...
    loading...
Cat. No.: HY-118931
CAS No.: 684645-54-3
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

EF-1502 is a potent and selective GABA transporter inhibitor with GAT1 and BGT1 inhibitory activity. EF-1502 produces a synergistic anti-epileptic effect when used in combination with Tiagabine (HY-B0696), a compound used to suppress epileptic seizures. The dosing combination of EF-1502 exhibited reduced anti-epileptic efficacy and dyskinesia when used with THIP (HY-10232). The mechanism of EF-1502 differs significantly from Tiagabine, suggesting a unique role in the inhibitory strategy [1].
loading...
    loading...
Cat. No.: HY-W033027
CAS No.: 406947-32-8
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

BGT1-IN-1 (compound 9) is a potent BGT1 inhibitor with IC50 value of 13.9, 58.3 µM for hBGT1, GAT3, respectively. BGT1-IN-1 shows no cytotoxic. BGT1-IN-1 shows neuroprotective activity [1].
loading...
    loading...
Cat. No.: HY-120146
CAS No.: 184845-43-0
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

NNC 05-2090 is aGABA uptake inhibitor and inhibitor of the β-GABA transporter (BGT-1) (IC50 sub>: 10.6 μM). NNC 05-2090 also inhibits mGAT2 with a Ki value of 1.4 μM. NNC 05-2090 has anticonvulsant activity and can be used in the study of epilepsy and neurological diseases [1] .
loading...
    loading...
Cat. No.: HY-181135
CAS No.: 1615763-33-1
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Bicyclo-GABA is a selective betaine/GABA transporter 1 (BGT1) competitive, non-transported inhibitor with an IC50 of 590 nM. Bicyclo-GABA exhibits low micromolar agonistic activity at α1β2γ2 GABAA receptors with an EC50 of 5.1 μM. Bicyclo-GABA displays 129 times higher activity for BGT1 than GAT3. Bicyclo-GABA serves as a valuable tool compound for deciphering its elusive pharmacological role in the brain and periphery [1].
loading...
    loading...
Cat. No.: HY-RS13298
Research Areas:  

Others

SLC6A12 Human Pre-designed siRNA Set A contains three designed siRNAs for SLC6A12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-103509R
CAS No.: 184845-18-9
Research Areas:  

Neurological Disease

NNC 05-2090 hydrochloride (Standard) is the analytical standard of NNC 05-2090 hydrochloride (HY-103509). This product is intended for research and analytical applications. NNC 05-2090 hydrochloride is a GABA uptake inhibitor and inhibitor of the β-GABA transporter (BGT-1) (IC50< /sub>: 10.6 μM). NNC 05-2090 hydrochloride also inhibits mGAT2 with a Ki value of 1.4 μM. NNC 05-2090 has anticonvulsant activity and can be used in the study of epilepsy and neurological diseases [1] .
loading...
    loading...
Cat. No.: HY-182944
CAS No.: 1265900-99-9
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

GATT-44 is a blood-brain barrier-permeable, selective GABA transporter 1 (GAT-1) ligand with an IC50 of 126 nM. GATT-44 shows selectivity for GAT-2, GAT-3 and BGT-1 subtypes, and undergoes copper-mediated 18F-radiofluorination. The radiolabeled GATT-44 ([ 18F]GATT-44) exhibits brain uptake, metabolic stability and high GAT-1 binding specificity in non-human primates. GATT-44 is applicable for research on neurodegenerative and neuropsychiatric diseases [1].
loading...
    loading...